Literature DB >> 10700235

Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells.

K M Braun1, J L Degen, E P Sandgren.   

Abstract

To provide long-term therapy in patients with severe toxin-induced hepatic parenchymal damage, donor hepatocytes would need to replicate and replace a large portion of the damaged parenchyma. Using a mouse model developed to reproduce this type of hepatic injury, we found that hepatocyte transplantation only slightly improved survival after transplantation despite the fact that many non-survivors showed moderate liver repopulation by donor cells. Perhaps accounting for this outcome, donor parenchyma in non-survivors did not have typical lobular organization. These results indicate that the re-creation of functional parenchyma by transplanted hepatocytes requires time, during which donor cells proliferate and then establish normal parenchymal architecture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700235     DOI: 10.1038/73179

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  17 in total

Review 1.  Advances in hepatocyte transplantation: a myth becomes reality.

Authors:  L A Lee
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 2.  Principles of therapeutic liver repopulation.

Authors:  Markus Grompe
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

3.  Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates.

Authors:  Olivier Menzel; Jacques Birraux; Barbara E Wildhaber; Caty Jond; Françoise Lasne; Walid Habre; Didier Trono; Tuan H Nguyen; Christophe Chardot
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

4.  Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes.

Authors:  T C Weglarz; J L Degen; E P Sandgren
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

5.  The reconstituted 'humanized liver' in TK-NOG mice is mature and functional.

Authors:  Masami Hasegawa; Kenji Kawai; Tetsuya Mitsui; Kenji Taniguchi; Makoto Monnai; Masatoshi Wakui; Mamoru Ito; Makoto Suematsu; Gary Peltz; Masato Nakamura; Hiroshi Suemizu
Journal:  Biochem Biophys Res Commun       Date:  2011-01-14       Impact factor: 3.575

6.  Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy.

Authors:  Sriram Bandi; Brigid Joseph; Ekaterine Berishvili; Rohit Singhania; Yao-Ming Wu; Kang Cheng; Sanjeev Gupta
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation.

Authors:  Harmeet Malhi; Giridhar R Gorla; Adil N Irani; Pallavi Annamaneni; Sanjeev Gupta
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

8.  Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.

Authors:  Donna N Douglas; Toshiyasu Kawahara; Banu Sis; David Bond; Karl P Fischer; D Lorne J Tyrrell; Jamie T Lewis; Norman M Kneteman
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

Review 9.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

10.  Effective hepatocyte transplantation using rat hepatocytes with low asialoglycoprotein receptor expression.

Authors:  Hirohiko Ise; Toshio Nikaido; Naoki Negishi; Nobuhiro Sugihara; Fumitaka Suzuki; Toshihiro Akaike; Uichi Ikeda
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.